Parallax Volatility Advisers, L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$555,660
+87.1%
27,000
+255.9%
0.00%
Q3 2022$297,000
+42.1%
7,586
+20.4%
0.00%
Q1 2022$209,000
-95.1%
6,300
-91.6%
0.00%
-100.0%
Q2 2021$4,278,000
+191.0%
75,300
+213.1%
0.00%
+300.0%
Q3 2020$1,470,000
-51.8%
24,051
+10.7%
0.00%
-66.7%
Q3 2019$3,047,000
-29.0%
21,723
-7.3%
0.00%
-40.0%
Q2 2019$4,289,000
-71.9%
23,424
-75.5%
0.01%
-70.6%
Q1 2019$15,237,000
+275.9%
95,800
+126.4%
0.02%
+183.3%
Q4 2018$4,053,000
+28.0%
42,313
+88.7%
0.01%
+50.0%
Q3 2018$3,167,000
+451.7%
22,421
+511.8%
0.00%
+300.0%
Q2 2018$574,000
-87.6%
3,665
-87.3%
0.00%
-83.3%
Q1 2018$4,637,000
+78.7%
28,794
+82.8%
0.01%
+100.0%
Q4 2017$2,595,000
-16.9%
15,754
-68.6%
0.00%
-40.0%
Q3 2017$3,121,000
-26.1%
50,100
-5.5%
0.01%
-37.5%
Q2 2017$4,221,000
+510.9%
52,996
+253.3%
0.01%
+700.0%
Q3 2016$691,00015,0000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders